Researcher.Life Logo

Journal of Aerosol Medicine and Pulmonary Drug Delivery : Impact Factor & More

eISSN: 1941-2703pISSN: 1941-2711

Key Metrics

CiteScore
5.1
Impact Factor
< 5
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Aerosol Medicine and Pulmonary Drug Delivery

Journal of Aerosol Medicine and Pulmonary Drug Delivery Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Aerosol Medicine and Pulmonary Drug Delivery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Aerosol Medicine and Pulmonary Drug Delivery

<i>Letter:</i> Revisiting NAC’s Multifaceted Role in Asthma Management: A Delicate Balance Between Anti‐Inflammatory Potential and Airway Defense Attenuation
  • 27 Nov 2025
  • Journal of Aerosol Medicine and Pulmonary Drug Delivery
Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, in Patients with Asthma or COPD, Evaluated Using Functional Respiratory Imaging.
  • 14 Nov 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Preclinical Studies of Clofazimine Inhalation Suspension: A Novel Formulation for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease.
  • 24 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Comment on "Association of Inhaled Corticosteroid Use with COVID-19 Severity and Hospitalization in Patients with and Without Respiratory Disease".
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Richard William Fuller-The Clinical Scientist Behind the Development of Multiple Leading Inhaled Therapies for Asthma (b. June 29, 1953-d. 2024).
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Response to Comment on "Association of Inhaled Corticosteroid Use With COVID-19 Severity and Hospitalization in Patients With and Without Respiratory Disease".
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
<i>Letter:</i> Revisiting NAC’s Multifaceted Role in Asthma Management: A Delicate Balance Between Anti‐Inflammatory Potential and Airway Defense Attenuation
  • 27 Nov 2025
  • Journal of Aerosol Medicine and Pulmonary Drug Delivery
Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, in Patients with Asthma or COPD, Evaluated Using Functional Respiratory Imaging.
  • 14 Nov 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Preclinical Studies of Clofazimine Inhalation Suspension: A Novel Formulation for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease.
  • 24 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Comment on "Association of Inhaled Corticosteroid Use with COVID-19 Severity and Hospitalization in Patients with and Without Respiratory Disease".
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Richard William Fuller-The Clinical Scientist Behind the Development of Multiple Leading Inhaled Therapies for Asthma (b. June 29, 1953-d. 2024).
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Response to Comment on "Association of Inhaled Corticosteroid Use With COVID-19 Severity and Hospitalization in Patients With and Without Respiratory Disease".
  • 1 Oct 2025
  • Journal of aerosol medicine and pulmonary drug delivery

FAQs on Journal of Aerosol Medicine and Pulmonary Drug Delivery